TABLE 9.
Genotype | Control group | SAP group | ACS group | F | p | |||
---|---|---|---|---|---|---|---|---|
n | PDGF‐BB (pg/ml) | n | PDGF‐BB (pg/ml) | n | PDGF‐BB (pg/ml) | |||
TT | 54 | 231.92 ± 129.79 | 53 | 235.99 ± 132.29 | 95 | 266.18 ± 117.73 | 1.690 | 0.187 |
TC + CC | 34 | 211.67 ± 75.20 | 29 | 221.81 ± 140.33 | 70 | 279.84 ± 144.71Δ$ | 4.030 | 0.020* |
t | 0.826 | 0.454 | −0.668 | |||||
p | 0.411 | 0.651 | 0.505 |
Note: PDGF‐BB level was shown by mean ± SD, and that among control group, SAP group, and ACS group of different genotypes were analyzed by univariate ANOVA (*p < 0.05). The pairwise comparison was analyzed by q test (Δcompared with control group p < 0.05; $compared with SAP group, p < 0.05). The comparison of PDGF‐BB level between TT and TC + CC genotypes was analyzed by t test (*p < 0.05).
Abbreviations: ACS, acute coronary syndrome; CHD, coronary heart disease; PDGF‐BB, platelet‐derived growth factor‐BB; SAP, stable angina pectoria.